Rhythm Pharmaceuticals (RYTM) Goodwill & Intangibles (2021 - 2026)

Rhythm Pharmaceuticals (RYTM) has 6 years of Goodwill & Intangibles data on file, last reported at $5.1 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $5.1 million, down 14.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (down 14.33% YoY), and the FY2025 annual result was $5.3 million, down 13.85% from the prior year.
• Goodwill & Intangibles slipped to $5.1 million in Q1 2026 per RYTM's latest filing, from $5.3 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $8.5 million in Q1 2022 and troughed at $5.1 million in Q1 2026.
• A 5-year average of $6.8 million and a median of $6.8 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles surged 70.54% in 2022, then retreated 14.33% in 2026.
• A 5-year view of Goodwill & Intangibles shows it stood at $7.9 million in 2022, then decreased by 10.85% to $7.0 million in 2023, then fell by 12.15% to $6.2 million in 2024, then fell by 13.85% to $5.3 million in 2025, then decreased by 4.0% to $5.1 million in 2026.
• Business Quant data shows RYTM's Goodwill & Intangibles at $5.1 million in Q1 2026, $5.3 million in Q4 2025, and $5.5 million in Q3 2025.